Phagenesis, Ltd: Phagenesis Launches Phagenyx Neurostimulation System in the U.S.
MANCHESTER, England, Oct. 10, 2022 /PRNewswire/ -- Phagenesis Ltd, today announced that the U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Phagenyx Neurostimulation
Source: finanznachrichten.de